Agree Slogger - would love it if management put out some more detail about current US sales data for Axiron.
An update on international (ex US) would also be useful.
I would also like more information about the following products:
Recuvyra
Ellavie (estradiol spray – EU)
Evamist (estradiol spray – US)
Testosterone MDTS for women
plans, markets, etc etc - at the moment its just too hard to understand the opportunities for these (and therefore accurately price the opportunity)
If anyone one is headed to the AGM - would love if they could press Management on these and other issues!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
-0.001(5.26%) |
Mkt cap ! $7.339M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $11.58K | 619.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 335415 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 516258 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |